Skip to content
Menu

Halozyme Therapeutics, Inc. HALO

Full chart Compare
Set alert

Price alert · HALO

All alert types
100.27 USD -0.40 (-0.40%)

At closeNov 13, 2026, 7:56 PM EST

99.48 -0.79 -0.79%

After hours · Nov 13, 7:56 PM ET

99.26 Day range 101.23
61.63 52-week range 131.18
YTD
+48.99%
1 year
+40.85%

Revenue & Expenses

Revenue → Gross Profit: $1.17BGross Profit → Net Income: $316.89MGross Profit → Selling, General & Admin: $207.09MGross Profit → Research & Development: $81.49MGross Profit → Other Operating Expenses: $76.66MRevenue → Cost of Revenue: $228.77MGross Profit → Interest Expense: $18.13MGross Profit → Other Expenses: $317.59MGross Profit → Income Tax: $149.99MGross Profit$1.17BCost of Revenue$228.77MNet Income$316.89MSelling, General & Admin$207.09MResearch & Development$81.49MOther Operating Expenses$76.66MInterest Expense$18.13MOther Expenses$317.59MIncome Tax$149.99MRevenue$1.40B

Latest period ending Dec 31, 2025 · select a line to chart its full history

Annual income statement

HALO annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
1.40B1.02B829.25M660.12M443.31M
1.40B1.02B829.25M660.12M443.31M
228.77M159.42M192.36M139.30M81.41M
1.17B855.91M636.89M520.81M361.90M
698.83M304.43M299.32M253.28M86.00M
366.38M79.05M76.36M66.61M35.67M
207.09M154.34M149.18M143.53M50.32M
469.01M551.48M337.57M267.53M275.90M
18.13M18.09M18.76M16.95M7.53M
149.99M113.04M66.73M46.79M-154.19M
316.89M444.09M281.59M202.13M402.71M
316.89M444.09M281.59M202.13M402.71M
316.89M444.09M281.59M202.13M402.71M
316.89M444.09M281.59M202.13M402.71M
2.643.502.131.482.86
2.643.502.131.482.86
2.563.432.101.442.74
485.00M575.23M367.09M265.87M256.04M
485.00M575.23M367.09M265.87M256.04M
119.84M126.83M131.93M136.84M140.65M
123.90M129.42M134.20M140.61M146.80M